Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Fossey

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Psychiatry|July 1, 1993
CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjectsR B Lydiard, T D Brewerton, M D Fossey, et al.
Biological Psychiatry|August 1, 1991
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorderL S Austin, R B Lydiard, J C Ballenger, et al.
The American Journal of Psychiatry|February 1, 1990
CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activityW H Kaye, J C Ballenger, R B Lydiard, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Psychiatry|July 1, 1993
CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjectsR B Lydiard, T D Brewerton, M D Fossey, et al.
Biological Psychiatry|August 1, 1991
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorderL S Austin, R B Lydiard, J C Ballenger, et al.
The American Journal of Psychiatry|February 1, 1990
CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activityW H Kaye, J C Ballenger, R B Lydiard, et al.
Pageof 2